FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387393291> ?p ?o ?g. }

• W4387393291 endingPage "e35391" @default.
• W4387393291 startingPage "e35391" @default.
• W4387393291 abstract "Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an immune-mediated inflammatory demyelinating disease of the central nervous system. This study aimed to delineate the clinical manifestations, imaging features, and long-term outcomes in Chinese patients with MOGAD and analyze the recurrence-associated factors. The phenotypic and neuroimaging characteristics of 15 Han Chinese patients with MOGAD were retrospectively analyzed. Demyelinating attacks, MOG antibodies in the cerebrospinal fluid/serum, response to immunotherapy, follow-up outcomes, and recurrence-associated factors were recorded. The median age at disease onset was 34 years (range, 4-65 years). The most common initial presentations included vision loss (10/15, 66.7%) and seizures (5/15, 33.3%). Serum MOG-Ab titers in 14/15 cases were higher than those in the cerebrospinal fluid and were detected in 3/6 relapsed patients. Brain magnetic resonance imaging during acute attacks showed lesions in 10/15 patients (66.7%), mostly in the cortex/subcortical white matter (5/15, 33.3%). Recurrence occurred in 6/15 patients (40.0%); in 4 patients, recurrence occurred shortly after immunotherapy discontinuation. Residual neurological deficits were present in 5/15 patients (33.3%), including visual impairment, incapacitation, cognitive impairment, and speech reduction. Optic neuritis was the most common clinical manifestation of MOGAD. magnetic resonance imaging findings were heterogeneous and the cerebral cortex/subcortical white matter was the most susceptible brain region. Although patients in the acute phase responded well to methylprednisolone pulse therapy, the long-term recurrence rate was high. Consistently detected serum MOG antibodies and inappropriate maintenance immunotherapy may be associated with recurrence, and residual neurological deficits should not be ignored." @default.
• W4387393291 created "2023-10-07" @default.
• W4387393291 creator A5002661071 @default.
• W4387393291 creator A5010516628 @default.
• W4387393291 creator A5023796403 @default.
• W4387393291 creator A5026349569 @default.
• W4387393291 creator A5044385614 @default.
• W4387393291 creator A5064022733 @default.
• W4387393291 creator A5064735710 @default.
• W4387393291 creator A5075594254 @default.
• W4387393291 creator A5080056172 @default.
• W4387393291 creator A5083217012 @default.
• W4387393291 date "2023-10-06" @default.
• W4387393291 modified "2023-10-11" @default.
• W4387393291 title "Clinical characteristics and long-term follow-up outcomes of myelin oligodendrocyte glycoprotein antibody-associated disease in Han Chinese participants" @default.
• W4387393291 cites W2542372902 @default.
• W4387393291 cites W2571925130 @default.
• W4387393291 cites W2598701066 @default.
• W4387393291 cites W2751963214 @default.
• W4387393291 cites W2767386734 @default.
• W4387393291 cites W2782439756 @default.
• W4387393291 cites W2800192720 @default.
• W4387393291 cites W2884356229 @default.
• W4387393291 cites W2893232755 @default.
• W4387393291 cites W2902875551 @default.
• W4387393291 cites W2905025446 @default.
• W4387393291 cites W2905137679 @default.
• W4387393291 cites W2941915623 @default.
• W4387393291 cites W2969292112 @default.
• W4387393291 cites W2982292416 @default.
• W4387393291 cites W2998980774 @default.
• W4387393291 cites W3012442290 @default.
• W4387393291 cites W3024734995 @default.
• W4387393291 cites W3037614566 @default.
• W4387393291 cites W3087282011 @default.
• W4387393291 cites W3096498029 @default.
• W4387393291 cites W3101190970 @default.
• W4387393291 cites W4206907339 @default.
• W4387393291 cites W4283071210 @default.
• W4387393291 cites W4293723971 @default.
• W4387393291 cites W4379471000 @default.
• W4387393291 doi "https://doi.org/10.1097/md.0000000000035391" @default.
• W4387393291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37800805" @default.
• W4387393291 hasPublicationYear "2023" @default.
• W4387393291 type Work @default.
• W4387393291 citedByCount "0" @default.
• W4387393291 crossrefType "journal-article" @default.
• W4387393291 hasAuthorship W4387393291A5002661071 @default.
• W4387393291 hasAuthorship W4387393291A5010516628 @default.
• W4387393291 hasAuthorship W4387393291A5023796403 @default.
• W4387393291 hasAuthorship W4387393291A5026349569 @default.
• W4387393291 hasAuthorship W4387393291A5044385614 @default.
• W4387393291 hasAuthorship W4387393291A5064022733 @default.
• W4387393291 hasAuthorship W4387393291A5064735710 @default.
• W4387393291 hasAuthorship W4387393291A5075594254 @default.
• W4387393291 hasAuthorship W4387393291A5080056172 @default.
• W4387393291 hasAuthorship W4387393291A5083217012 @default.
• W4387393291 hasBestOaLocation W43873932911 @default.
• W4387393291 hasConcept C126322002 @default.
• W4387393291 hasConcept C126838900 @default.
• W4387393291 hasConcept C142724271 @default.
• W4387393291 hasConcept C143409427 @default.
• W4387393291 hasConcept C203014093 @default.
• W4387393291 hasConcept C2776572573 @default.
• W4387393291 hasConcept C2778609137 @default.
• W4387393291 hasConcept C2778715236 @default.
• W4387393291 hasConcept C2779357208 @default.
• W4387393291 hasConcept C2780640218 @default.
• W4387393291 hasConcept C2781192897 @default.
• W4387393291 hasConcept C529278444 @default.
• W4387393291 hasConcept C71924100 @default.
• W4387393291 hasConceptScore W4387393291C126322002 @default.
• W4387393291 hasConceptScore W4387393291C126838900 @default.
• W4387393291 hasConceptScore W4387393291C142724271 @default.
• W4387393291 hasConceptScore W4387393291C143409427 @default.
• W4387393291 hasConceptScore W4387393291C203014093 @default.
• W4387393291 hasConceptScore W4387393291C2776572573 @default.
• W4387393291 hasConceptScore W4387393291C2778609137 @default.
• W4387393291 hasConceptScore W4387393291C2778715236 @default.
• W4387393291 hasConceptScore W4387393291C2779357208 @default.
• W4387393291 hasConceptScore W4387393291C2780640218 @default.
• W4387393291 hasConceptScore W4387393291C2781192897 @default.
• W4387393291 hasConceptScore W4387393291C529278444 @default.
• W4387393291 hasConceptScore W4387393291C71924100 @default.
• W4387393291 hasIssue "40" @default.
• W4387393291 hasLocation W43873932911 @default.
• W4387393291 hasLocation W43873932912 @default.
• W4387393291 hasOpenAccess W4387393291 @default.
• W4387393291 hasPrimaryLocation W43873932911 @default.
• W4387393291 hasRelatedWork W1988778679 @default.
• W4387393291 hasRelatedWork W2056314285 @default.
• W4387393291 hasRelatedWork W2128894747 @default.
• W4387393291 hasRelatedWork W2134402139 @default.
• W4387393291 hasRelatedWork W2774306101 @default.
• W4387393291 hasRelatedWork W2888530409 @default.
• W4387393291 hasRelatedWork W3197684187 @default.
• W4387393291 hasRelatedWork W534476 @default.
• W4387393291 hasRelatedWork W634508357 @default.

• next